235 related articles for article (PubMed ID: 26564318)
21. Preparation and identification of multifunctional mesoporous silica nanoparticles for in vitro and in vivo dual-mode imaging, theranostics, and targeted tracking.
Chan MH; Lin HM
Biomaterials; 2015 Apr; 46():149-58. PubMed ID: 25678124
[TBL] [Abstract][Full Text] [Related]
22. Development of a novel imaging system for cell therapy in the brain.
Micci MA; Boone DR; Parsley MA; Wei J; Patrikeev I; Motamedi M; Hellmich HL
Stem Cell Res Ther; 2015 Jul; 6(1):131. PubMed ID: 26194790
[TBL] [Abstract][Full Text] [Related]
23. Improved synthesis of no-carrier-added p-[124I]iodo-L-phenylalanine and p-[131I]iodo-L-phenylalanine for nuclear medicine applications in malignant gliomas.
Israel I; Brandau W; Farmakis G; Samnick S
Appl Radiat Isot; 2008 Apr; 66(4):513-22. PubMed ID: 18024046
[TBL] [Abstract][Full Text] [Related]
24. Inflammatory bowel disease: MR- and SPECT/CT-based macrophage imaging for monitoring and evaluating disease activity in experimental mouse model--pilot study.
Wu Y; Briley-Saebo K; Xie J; Zhang R; Wang Z; He C; Tang CY; Tao X
Radiology; 2014 May; 271(2):400-7. PubMed ID: 24475849
[TBL] [Abstract][Full Text] [Related]
25. Radioiodine-labeled anti-epidermal growth factor receptor binding bovine serum albumin-polycaprolactone for targeting imaging of glioblastoma.
Li C; Tan J; Chang J; Li W; Liu Z; Li N; Ji Y
Oncol Rep; 2017 Nov; 38(5):2919-2926. PubMed ID: 28901480
[TBL] [Abstract][Full Text] [Related]
26. Independent thallium-201 accumulation and fluorine-18-fluorodeoxyglucose metabolism in glioma.
Oriuchi N; Tomiyoshi K; Inoue T; Ahmad K; Sarwar M; Tokunaga M; Suzuki H; Watanabe N; Hirano T; Horikoshi S; Shibasaki T; Tamura M; Endo K
J Nucl Med; 1996 Mar; 37(3):457-62. PubMed ID: 8772644
[TBL] [Abstract][Full Text] [Related]
27. Intravascular delivery of neural stem cell lines to target intracranial and extracranial tumors of neural and non-neural origin.
Brown AB; Yang W; Schmidt NO; Carroll R; Leishear KK; Rainov NG; Black PM; Breakefield XO; Aboody KS
Hum Gene Ther; 2003 Dec; 14(18):1777-85. PubMed ID: 14670128
[TBL] [Abstract][Full Text] [Related]
28. Dual-labeled trastuzumab-based imaging agent for the detection of human epidermal growth factor receptor 2 overexpression in breast cancer.
Sampath L; Kwon S; Ke S; Wang W; Schiff R; Mawad ME; Sevick-Muraca EM
J Nucl Med; 2007 Sep; 48(9):1501-10. PubMed ID: 17785729
[TBL] [Abstract][Full Text] [Related]
29. Preclinical evaluation of [¹¹¹ In]-DOTA-trastuzumab for clinical trials.
Alirezapour B; Jalilian AR; Rajabifar S; Mirzaii M; Moradkhani S; Pouladi M; Aslani G
J Cancer Res Ther; 2014; 10(1):112-20. PubMed ID: 24762497
[TBL] [Abstract][Full Text] [Related]
30. Monitoring therapeutic response of human ovarian cancer to trastuzumab by SPECT imaging with (99m)Tc-peptide-Z(HER2:342).
Zhang J; Zhao X; Wang S; Wang N; Han J; Jia L; Ren X
Nucl Med Biol; 2015 Jun; 42(6):541-6. PubMed ID: 25735223
[TBL] [Abstract][Full Text] [Related]
31. In Vivo Targeted MR Imaging of Endogenous Neural Stem Cells in Ischemic Stroke.
Zhang F; Duan X; Lu L; Zhang X; Zhong X; Mao J; Chen M; Shen J
Molecules; 2016 Aug; 21(9):. PubMed ID: 27589699
[TBL] [Abstract][Full Text] [Related]
32. MicroPET/CT imaging of an orthotopic model of human glioblastoma multiforme and evaluation of pulsed low-dose irradiation.
Park SS; Chunta JL; Robertson JM; Martinez AA; Oliver Wong CY; Amin M; Wilson GD; Marples B
Int J Radiat Oncol Biol Phys; 2011 Jul; 80(3):885-92. PubMed ID: 21489704
[TBL] [Abstract][Full Text] [Related]
33. Neural stem cells preferentially migrate to glioma stem cells and reduce their stemness phenotypes.
Zhang S; Xie R; Zhao T; Yang X; Han L; Ye F; Lei T; Wan F
Int J Oncol; 2014 Nov; 45(5):1989-96. PubMed ID: 25176161
[TBL] [Abstract][Full Text] [Related]
34. Hybrid Metal-Phenol Nanoparticles with Polydopamine-like Coating for PET/SPECT/CT Imaging.
Suárez-García S; Esposito TVF; Neufeld-Peters J; Bergamo M; Yang H; Saatchi K; Schaffer P; Häfeli UO; Ruiz-Molina D; Rodríguez-Rodríguez C; Novio F
ACS Appl Mater Interfaces; 2021 Mar; 13(9):10705-10718. PubMed ID: 33635046
[TBL] [Abstract][Full Text] [Related]
35. Developing Bioinspired Three-Dimensional Models of Brain Cancer to Evaluate Tumor-Homing Neural Stem Cell Therapy.
Carey-Ewend AG; Hagler SB; Bomba HN; Goetz MJ; Bago JR; Hingtgen SD
Tissue Eng Part A; 2020 Oct; ():. PubMed ID: 33085922
[TBL] [Abstract][Full Text] [Related]
36. PET/MRI dual-modality tumor imaging using arginine-glycine-aspartic (RGD)-conjugated radiolabeled iron oxide nanoparticles.
Lee HY; Li Z; Chen K; Hsu AR; Xu C; Xie J; Sun S; Chen X
J Nucl Med; 2008 Aug; 49(8):1371-9. PubMed ID: 18632815
[TBL] [Abstract][Full Text] [Related]
37. Multimodal Molecular Imaging Reveals High Target Uptake and Specificity of 111In- and 68Ga-Labeled Fibrin-Binding Probes for Thrombus Detection in Rats.
Oliveira BL; Blasi F; Rietz TA; Rotile NJ; Day H; Caravan P
J Nucl Med; 2015 Oct; 56(10):1587-92. PubMed ID: 26251420
[TBL] [Abstract][Full Text] [Related]
38. Neural stem cells improve intracranial nanoparticle retention and tumor-selective distribution.
Mooney R; Weng Y; Tirughana-Sambandan R; Valenzuela V; Aramburo S; Garcia E; Li Z; Gutova M; Annala AJ; Berlin JM; Aboody KS
Future Oncol; 2014 Feb; 10(3):401-15. PubMed ID: 24559447
[TBL] [Abstract][Full Text] [Related]
39. Evaluation of prognostic integrin α2β1 PET tracer and concurrent targeting delivery using focused ultrasound for brain glioma detection.
Chung YH; Hsu PH; Huang CW; Hsieh WC; Huang FT; Chang WC; Chiu H; Hsu ST; Yen TC
Mol Pharm; 2014 Nov; 11(11):3904-14. PubMed ID: 25153169
[TBL] [Abstract][Full Text] [Related]
40. Cell penetrating peptide functionalized perfluorocarbon nanoemulsions for targeted cell labeling and enhanced fluorine-19 MRI detection.
Hingorani DV; Chapelin F; Stares E; Adams SR; Okada H; Ahrens ET
Magn Reson Med; 2020 Mar; 83(3):974-987. PubMed ID: 31631402
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]